Stage 3 lung cancer is considered locally advanced with spread in the region near the site. Survival rates for stage 3 non-small cell lung cancer (NSCLC) range from as high as 36% to as low as 13%, ...

CHICOPEE, Mass. (WWLP) – World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease. The American Lung Association states that lung ...

Lung (pulmonary) sarcoma is a rare type of lung cancer. Most lung cancers start in epithelial cells that line your airways, but pulmonary sarcoma develops in connective tissue or other nonepithelial ...

Precision-targeted radiation is proving a match for surgery in early-stage lung cancer, offering patients similar long-term survival with less invasiveness, and potentially transforming how this ...

Multidisciplinary evaluation, including thoracic surgical consultation, is crucial for oligometastatic NSCLC patients to optimize treatment strategies. Lung surgery for oligometastatic NSCLC shows ...

How Well Does Tagrisso Work for Lung Cancer? The FDA approved Tagrisso based on clinical trials for EGFR-mutated lung cancer in several different scenarios. Tagrisso was studied in people who had lung ...

Robotic and video-assisted thoracic surgery have revolutionized lung cancer treatment, minimizing trauma and shortening recovery times. Minimally invasive techniques enable complex procedures, ...

The FDA approved Keytruda for NSCLC based on several clinical trials. Keytruda was studied in people whose NSCLC had spread to other parts of the body (metastatic) and who had received no prior ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with ...